28 Oct 2021
Invitation to presentation of Xbrane Biopharma’s interim report January – September, 2021 on October 29, 2021.
11 Oct 2021
Xbrane announces two granted patents that strengthens its high yield protein expression platform
07 Oct 2021
Xbrane Biopharma and AGC Biologics enter into an Agreement to Manufacture Xcimzane™ for Clinical Development
30 Sep 2021
Xbrane Biopharma AB announces that partner STADA’s Marketing Authorization Application for ranibizumab is submitted and validated by European Medicines Agency
11 Aug 2021
Invitation to presentation of Xbrane Biopharma’s interim report January – June, 2021 on August 13, 2021.
30 Jun 2021
Xbrane Biopharma has carried out a directed share issue raising gross proceeds of SEK 380 millions